A place to pace: Multimodal imaging for atrial leadless pacemaker implantation
Abstract
The recent approval of a leadless atrial pacemaker (ALP, AVEIR™, Abbott, USA) has enabled the benefits of leadless pacing and afforded renewed interest in standalone atrial pacing in patients with isolated sinus node dysfunction. Per manufacturer’s recommendation, implantation is guided by fluoroscopy and contrast injections to first delineate the anatomy of the right atrial appendage (RAA).1 The ALP is ideally implanted at the base of the RAA where adequate myocardial thickness provides a suitable anchor and minimizes the risk of perforation.
Fields of Study & Subjects
Cardiac pacing and defibrillation studies
Atrial Fibrillation Management and Outcomes
Cardiac Arrhythmias and Treatments
Publication details
- Journal / source
- HeartRhythm Case Reports
- Volume
- 12
- Issue
- 4
- Pages
- 432–436
- Publication date
- 10 January 2026
- Language
- EN